InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（167 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
167
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Booth Bruce, 董事长兼首席执行官. Officer active across 5 companies, notably Kymera Therapeutics, Inc.. Cumulatively, 177 disclosures have been recorded. Split: 0 buy · 167 sells. Total volume traded: €55.6m. History available since 11 August 2021. The latest transaction was disclosed on 22 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Booth Bruce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报177 总计
28,296 股Common StockSEC:0001451612-26-000018:0
231,007 股Common StockSEC:0001451612-26-000018:1
32,624 股Common StockSEC:0001451612-26-000018:2
11,277 股Common StockSEC:0001451612-26-000018:3
10,366 股Common StockSEC:0001451612-26-000018:4
555 股Common StockSEC:0001451612-26-000018:5
14,913 股Common StockSEC:0001451612-26-000018:6
27,951 股Common StockSEC:0001451612-26-000018:7
6,821 股Common StockSEC:0001451612-26-000018:8
12,181 股Common StockSEC:0001451612-26-000018:9
22,046 股Common StockSEC:0001451612-26-000018:10
12,390 股Common StockSEC:0001451612-26-000018:11
3,958 股Common StockSEC:0001451612-26-000018:12
32,402 股Common StockSEC:0001451612-26-000018:13
4,562 股Common StockSEC:0001451612-26-000018:14
1,579 股Common StockSEC:0001451612-26-000018:15
1,442 股Common StockSEC:0001451612-26-000018:16
78 股Common StockSEC:0001451612-26-000018:17
2,083 股Common StockSEC:0001451612-26-000018:18
3,896 股Common StockSEC:0001451612-26-000018:19
952 股Common StockSEC:0001451612-26-000018:20
1,701 股Common StockSEC:0001451612-26-000018:21
3,069 股Common StockSEC:0001451612-26-000018:22
1,729 股Common StockSEC:0001451612-26-000018:23
5,471 股Common StockSEC:0001451612-26-000018:24
177 条申报中的 25 条
About Booth Bruce
Booth Bruce is President and Chief Executive Officer and a Director at Kymera Therapeutics, Inc., Sionna Therapeutics, Inc., Vigil Neuroscience, Inc., and ZAFGEN, INC. He has 177 filings in total, and the 177 tracked filings consist only of sales, with EUR 55,638,394 in sales over the period from 2016-01-27 to 2026-06-30.
